|
About the Events / Workshops / Webinars category
|
|
0
|
606
|
April 14, 2021
|
|
N-nitroso-Duloxetine recall back in the news!
|
|
12
|
2042
|
December 13, 2024
|
|
👨💻 FDA-CRCG NDSRI Workshop
|
|
0
|
505
|
December 5, 2024
|
|
📅 Updates on Approaches to Acceptable Intakes of Nitrosamine Drug Substance Related Impurities (NDSRIs) and Bioequivalence Assessment for Reformulated Drug Products(CRCG)
|
|
35
|
2795
|
December 3, 2024
|
|
Free webinar: From Ambiguity to Action, The FDA's New Nitrosamine Guidance
|
|
1
|
555
|
December 2, 2024
|
|
Small Nitrosamines in excipeints
|
|
11
|
339
|
November 21, 2024
|
|
📅 Analytical challenges and the effective management of nitrosamines: The evolving landscape of NDSRI analysis
|
|
3
|
481
|
October 30, 2024
|
|
AAPS PharmSci360 -Nitrosamines
|
|
13
|
418
|
October 22, 2024
|
|
Royal Australian Chemical Institute
|
|
0
|
79
|
September 26, 2024
|
|
57th Congress of the European Societies of Toxicology (EUROTOX 2023)
|
|
2
|
684
|
September 24, 2024
|
|
Facing Up to the New Nemesis of Pharma: Nitrosamines What’s going on with nitrosamines in pharmaceutical products? Naiffer Romero, Principal Scientist at the US Pharmacopeia walks us through frequently asked questions
|
|
0
|
181
|
September 23, 2024
|
|
9th Impurities: Genotoxic, Nitrosamine, & Beyond Summit
|
|
0
|
329
|
September 18, 2024
|
|
PMDA-USP Workshop - Nitrosamines Track
|
|
2
|
491
|
September 17, 2024
|
|
FDA-CDER and HESI | Nitrosamine Ames Data Review and Method Development Workshop
|
|
1
|
236
|
September 17, 2024
|
|
Potential Topic for an event concerning obtaining the right level of Nitrosamine Risk Assessment information from your CMOs
|
|
23
|
1616
|
September 8, 2024
|
|
📅 FDA - CRCG Updates on Approaches to Acceptable Intakes of Nitrosamine Drug Substance Related Impurities (NDSRIs) and Bioequivalence Assessment for Reformulated Drug Products -Event
|
|
1
|
949
|
August 14, 2024
|
|
IPEC Webinar on the role of excipients in determine N-nitrosamine risks
|
|
3
|
448
|
July 24, 2024
|
|
Classification of potentially mutagenic impurities under the ICH M7 guideline -Event
|
|
0
|
373
|
July 23, 2024
|
|
Nitrosamine in vivo mutagenicity workshop
|
|
10
|
763
|
July 22, 2024
|
|
Nitrosamine impurities in medicines (presented at the ARCS Annual Conference 2024)
|
|
12
|
1058
|
July 17, 2024
|
|
USP India - Nitrosamines panel discussion at USP Science Conclave
|
|
0
|
353
|
July 10, 2024
|
|
EPR Podcast Ep 26 – Navigating Nitrosamine Impurities
|
|
0
|
368
|
June 26, 2024
|
|
Predicting Nitrosamine Formation in the Solid State
|
|
3
|
711
|
June 24, 2024
|
|
Common Template for initial assessment of Nitrosamine impurities
|
|
0
|
646
|
June 20, 2024
|
|
Insights from the Lhasa Limited and IPEC Europe Nitrites collaborative meeting
|
|
1
|
510
|
June 16, 2024
|
|
🇺🇸 FDA - Fiscal Year 2024 Generic Drug Science and Research Initatives Public Workshop
|
|
33
|
1921
|
September 5, 2024
|
|
🇲🇽 Conferencia USP Nitrosaminas en México presencial 21-Marzo
|
|
4
|
721
|
May 27, 2024
|
|
Managing the complexities of NDSRI method development: The N-nitroso propranolol case story
|
|
0
|
526
|
May 14, 2024
|
|
Using the Carcinogenicity Potency Categorization Algorithm to Predict N-Nitrosamine Carcinogenicity -Webinar
|
|
0
|
353
|
May 13, 2024
|
|
🇺🇸 FDA CDER Generic Drug Forum (GDF) 2024
|
|
5
|
1366
|
April 14, 2024
|